The recent disruptions in global chains have highlighted the necessity of securing essential medications like Ivermectin. Relying on overseas producers exposes nations to considerable vulnerabilities, including delivery delays, cost fluctuations, and even geopolitical risks. Shifting towards domestic procurement of Ivermectin offers a multitude of